Literature DB >> 16557689

In vitro detection of antibody to cholera enterotoxin in cholera patients and laboratory animals.

R A Finkelstein1, J W Peterson.   

Abstract

Two new in vitro microtests for anticholeragen (cholera exo-enterotoxin) antibodies are described and compared. In both tests, choleragen and choleragenoid, antigenically identical purified moieties which differ in size, charge, and toxicity, may be used as sensitizing antigens with apparently equal facility. The passive hemagglutination (PHA) test in which sensitized tanned chicken erythrocytes are used was found to be more sensitive than the sensitized bentonite flocculation test. Tests with sera from cholera patients almost invariably demonstrated a rise in titer on convalescence. Results with the PHA test were directly correlated with results derived from in vivo toxin neutralization assays involving inhibition of skin reactivity and the ileal loop reaction. These observations strengthen the hypothesis that choleragen is involved in the pathogenesis of cholera in man and support the unitarian concept that skin reactivity and choleragenesis are manifestations of the same toxin acting in different tissues. Both of the tests described have been modified and used as inhibition tests in the detection and assay of choleragen antigen.

Entities:  

Year:  1970        PMID: 16557689      PMCID: PMC415849          DOI: 10.1128/iai.1.1.21-29.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Immunity against experimental cholera.

Authors:  R A Finkelstein; P Atthasampunna
Journal:  Proc Soc Exp Biol Med       Date:  1967-06

Review 2.  Status of bacterial toxins and their nomenclature: need for discipline and clarity of expression.

Authors:  P F Bonventre; R E Lincoln; C Lamanna
Journal:  Bacteriol Rev       Date:  1967-06

3.  In vitro production of choleragen and vascular permeability factor by Vibrio cholerae.

Authors:  D J Evans; S H Richardson
Journal:  J Bacteriol       Date:  1968-07       Impact factor: 3.490

4.  Neutralization of the vascular permeability factor of Vibrio Cholerae in man.

Authors:  A R Martin; T M Vernon; W H Mosley
Journal:  Am J Trop Med Hyg       Date:  1969-03       Impact factor: 2.345

5.  The titration of cholera toxin and antitoxin in the rabbit ileal loop.

Authors:  G J Kasai; W Burrows
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

6.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

7.  Pathogenesis of experimental cholera: identification of choleragen (procholeragen A) by disc immunoelectrophoresis and its differentiation from cholera mucinase.

Authors:  R A Finkelstein; P Z Sobocinski; P Atthasampunna; P Charunmethee
Journal:  J Immunol       Date:  1966-07       Impact factor: 5.422

8.  Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan.

Authors:  A S Benenson; A Saad; W H Mosley; A Ahmed
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

9.  Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.

Authors:  A S Benenson; A Saad; W H Mosley
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

10.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

View more
  19 in total

1.  Antibody against Clostridium perfringens type A enterotoxin in human sera.

Authors:  T Uemura; C Genigeorgis; H P Riemann; C E Franti
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

2.  Experimental studies on cholera immunization. II. Evidence for protective antitoxic immunity mediated by serum antibodies as well as local antibodies.

Authors:  J Holmgren; A Andersson; G Wallerstrom; O Ouchterlony
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

3.  Protection against experimental cholera by oral or parenteral immunization.

Authors:  J W Peterson
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

4.  Characterization of the antigenic determinants of cholera toxin subunits.

Authors:  D E Markel; K E Hejtmancik; J W Peterson; F B Martin; A Kurosky
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

5.  Inhibition of immune hemolysis: serological assay for the heat-labile enterotoxin of Excherichia coli.

Authors:  D J Evans; D G Evans
Journal:  J Clin Microbiol       Date:  1977-01       Impact factor: 5.948

6.  Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.

Authors:  H D Hochstein; J C Feeley; W E DeWitt
Journal:  Appl Microbiol       Date:  1970-05

7.  Quantitative measurements of cholera enterotoxin in cultures of toxinogenic wild-type and nontoxinogenic mutant strains of Vibrio cholerae by using a sensitive and specific reversed passive hemagglutination assay for cholera enerotoxin.

Authors:  R K Holmes; W B Baine; M L Vasil
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

8.  Radial passive immune hemolysis assay for detection of heat-labile enterotoxin produced by individual colonies of Escherichia coli or Vibrio cholerae.

Authors:  M G Bramucci; R K Holmes
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

9.  Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.

Authors:  J W Peterson
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

10.  Properties of the cholera exo-enterotoxin: effects of dispersing agents and reducing agents in gel filtration and electrophoresis.

Authors:  R A Finkelstein; M K LaRue; J J LoSpalluto
Journal:  Infect Immun       Date:  1972-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.